ATE483714T1 - Podophyllotoxine als antiproliferative mittel - Google Patents

Podophyllotoxine als antiproliferative mittel

Info

Publication number
ATE483714T1
ATE483714T1 AT02791768T AT02791768T ATE483714T1 AT E483714 T1 ATE483714 T1 AT E483714T1 AT 02791768 T AT02791768 T AT 02791768T AT 02791768 T AT02791768 T AT 02791768T AT E483714 T1 ATE483714 T1 AT E483714T1
Authority
AT
Austria
Prior art keywords
podophyllotoxins
antiproliferative agents
antiproliferative
agents
production
Prior art date
Application number
AT02791768T
Other languages
English (en)
Inventor
Gerhard Gaedicke
Holger Lode
Wolfgang Wrasidlo
Original Assignee
Universitaetsklinikum Charite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7708614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE483714(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Universitaetsklinikum Charite filed Critical Universitaetsklinikum Charite
Application granted granted Critical
Publication of ATE483714T1 publication Critical patent/ATE483714T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02791768T 2001-12-03 2002-12-03 Podophyllotoxine als antiproliferative mittel ATE483714T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10160515 2001-12-03
PCT/EP2002/013669 WO2003048166A1 (en) 2001-12-03 2002-12-03 Podophyllotoxins as antiproliferative agents

Publications (1)

Publication Number Publication Date
ATE483714T1 true ATE483714T1 (de) 2010-10-15

Family

ID=7708614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02791768T ATE483714T1 (de) 2001-12-03 2002-12-03 Podophyllotoxine als antiproliferative mittel

Country Status (10)

Country Link
US (1) US7582778B2 (de)
EP (2) EP1451193B1 (de)
JP (2) JP4527978B2 (de)
AT (1) ATE483714T1 (de)
AU (1) AU2002358086B2 (de)
CA (1) CA2468479C (de)
DE (1) DE60237915D1 (de)
DK (1) DK2327705T3 (de)
ES (2) ES2545393T3 (de)
WO (1) WO2003048166A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
AU2002358086B2 (en) * 2001-12-03 2009-06-04 Universitatsklinikum Charite Der Humboldt-Universitat Zu Berlin Technologie Transferstelle Podophyllotoxins as antiproliferative agents
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
EP2274617A4 (de) 2008-04-10 2011-11-09 Massachusetts Inst Technology Verfahren zur erkennung und verwendung von auf krebsstammzellen abzielenden mitteln
AU2010232556A1 (en) * 2009-04-02 2011-11-03 Allergan, Inc. Prostaglandin E receptor antagonists
US9889147B2 (en) 2010-04-16 2018-02-13 Cellact Pharma Gmbh Analogues of etoposide for the treatment of tumours
CN102070645B (zh) * 2011-01-07 2015-04-22 兰州大学 一种脱氧鬼臼毒素类化合物及其制备与应用
US10106778B2 (en) 2012-11-08 2018-10-23 Whitehead Institute For Biomedical Research Selective targeting of cancer stem cells
GB2513299A (en) 2013-03-12 2014-10-29 Cellact Pharma Gmbh Biomedizinzentrum Compounds for targeting cancer stem cells
WO2015168255A1 (en) 2014-04-29 2015-11-05 Whitehead Institute For Biomedical Research Methods and compositions for targeting cancer stem cells
EP3211091A1 (de) * 2016-02-24 2017-08-30 CellAct Pharma GmbH Verfahren zur diagnose von mit etoposid-prodrug behandelbarem krebs
KR20230131815A (ko) * 2020-08-19 2023-09-14 셀액트 파마 게엠베하 에토포시드 토니리베이트 제제
CN116178469A (zh) * 2023-02-08 2023-05-30 汤亚杰 寡核苷酸修饰鬼臼毒素类衍生物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
NZ225599A (en) * 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells
ZA886810B (en) * 1987-12-18 1989-08-30 Bristol Myers Co Epipodophyllotoxin glucoside 4'-acyl derivatives
US5411947A (en) 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
DE3935016A1 (de) 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
US6610841B1 (en) 1997-12-18 2003-08-26 Gilead Sciences, Inc. Nucleotide-based prodrugs
CA2122036C (en) 1991-10-23 2002-09-17 Gillian Anlezark Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
DE4236237A1 (de) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
US5605976A (en) 1995-05-15 1997-02-25 Enzon, Inc. Method of preparing polyalkylene oxide carboxylic acids
WO1998013059A1 (en) 1996-09-27 1998-04-02 Bristol-Myers Squibb Company Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
AU2002358086B2 (en) * 2001-12-03 2009-06-04 Universitatsklinikum Charite Der Humboldt-Universitat Zu Berlin Technologie Transferstelle Podophyllotoxins as antiproliferative agents

Also Published As

Publication number Publication date
CA2468479C (en) 2010-04-27
AU2002358086A1 (en) 2003-06-17
EP2327705A1 (de) 2011-06-01
US7582778B2 (en) 2009-09-01
WO2003048166A1 (en) 2003-06-12
EP2327705B1 (de) 2015-05-27
CA2468479A1 (en) 2003-06-12
EP1451193B1 (de) 2010-10-06
JP2005517645A (ja) 2005-06-16
DK2327705T3 (en) 2015-08-24
ES2545393T3 (es) 2015-09-10
EP1451193A1 (de) 2004-09-01
JP5302862B2 (ja) 2013-10-02
US20060293254A1 (en) 2006-12-28
DE60237915D1 (en) 2010-11-18
JP4527978B2 (ja) 2010-08-18
ES2354065T3 (es) 2011-03-09
JP2010120943A (ja) 2010-06-03
AU2002358086B2 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
NO20091976L (no) Nye forbindelser
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
BR0212250B1 (pt) produto de cuidado pessoal.
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DK1446387T3 (da) Substituerede aryl, 1,4-pyrazinderivater
DE60234264D1 (de) Spiro-hydantoin-verbindungen, die sich als entzündungshemmende mittel eignen
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
DE60238917D1 (de) Modifikation des ölprofils von pflanzen
DE60217432D1 (de) Verwendungen von Kohlenstofffasern
ATE402272T1 (de) Martensitische nanoverbundstähle
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE483714T1 (de) Podophyllotoxine als antiproliferative mittel
DK1385518T3 (da) Benzimidazolon-forbindelser
BR0210823B1 (pt) polia e conjunto de polia.
ATE323095T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
FR2831442B1 (fr) Composition cosmetique mimant le sebum, et utilisations
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
DE60201463D1 (de) Indanon-Derivate als Duftstoffe
ATE332902T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
BR0206922A (pt) Compostos orgânicos
DE60324753D1 (de) Antiallergische, antibakterielle und rötungsmindernde Augenzusammensetzung
ATE335766T1 (de) Antikörper gegen caspase-8, ihre herstellung und verwendung
ES1048629Y (es) Forjado alveolar ligero.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties